Search

everythinglearnresearchcommunity

for

Search:↓

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Lotions release minoxidil better than creams, with a recommended mix of propylene glycol, water, and ethanol improving effectiveness.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

The document is a detailed medical reference on skin and genetic disorders.

Removing a testicular tumor in a dog reduced its aggressive behavior and skin problems.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

Researchers found certain genes are overactive and others are underactive in men with early balding, which could help create new treatments.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

A cat's hair loss was linked to a severe pancreatic cancer.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Tempol is safe and may prevent hair loss from brain radiotherapy.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.